TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
DaVita ( (DVA) ) has provided an update.
DaVita has announced a strategic initiative aimed at enhancing its operational efficiency and improving patient care. This move is expected to strengthen DaVita’s position in the healthcare industry by streamlining its processes and potentially leading to better outcomes for stakeholders.
The most recent analyst rating on (DVA) stock is a Hold with a $140.00 price target. To see the full list of analyst forecasts on DaVita stock, see the DVA Stock Forecast page.
Spark’s Take on DVA Stock
According to Spark, TipRanks’ AI Analyst, DVA is a Neutral.
DaVita’s overall stock score reflects strong financial performance and reasonable valuation, but is tempered by bearish technical indicators and challenges highlighted in the earnings call. The company’s strategic financial moves are positive, but the impact of high leverage and declining treatment volumes remains a concern.
To see Spark’s full report on DVA stock, click here.
More about DaVita
Average Trading Volume: 829,100
Technical Sentiment Signal: Buy
Current Market Cap: $9.77B
For detailed information about DVA stock, go to TipRanks’ Stock Analysis page.